Therefore, this epigenetic dysregulation disrupts the tissue-specific expression of TOP2A, leading to its aberrant activation in cholangiocytes and resulting in genomic instability and abnormal cell proliferation in BA cholangiocytes. Here, TOP2A is linked to breast angiosarcoma.